Bill Text: NJ A4824 | 2018-2019 | Regular Session | Introduced


Bill Title: Requires written instructions for, and dispensations of, medical marijuana be reported to prescription monitoring database.

Spectrum: Partisan Bill (Democrat 3-0)

Status: (Introduced) 2018-12-17 - Introduced, Referred to Assembly Health and Senior Services Committee [A4824 Detail]

Download: New_Jersey-2018-A4824-Introduced.html

ASSEMBLY, No. 4824

STATE OF NEW JERSEY

218th LEGISLATURE

 

INTRODUCED DECEMBER 17, 2018

 


 

Sponsored by:

Assemblyman  HERB CONAWAY, JR.

District 7 (Burlington)

 

 

 

 

SYNOPSIS

     Requires written instructions for, and dispensations of, medical marijuana be reported to prescription monitoring database.

 

CURRENT VERSION OF TEXT

     As introduced.

 


An Act concerning medical marijuana and amending P.L.2009, c.309 and P.L.2007, c.244.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    Section 10 of P.L.2009, c.307 (C.24:6I-10) is amended to read as follows:

     10.  a.   A physician shall provide written instructions for a registered qualifying patient or his caregiver to present to an alternative treatment center concerning the total amount of usable marijuana that a patient may be dispensed, in weight, in a 30-day period, which amount shall not exceed two ounces.  If no amount is noted, the maximum amount that may be dispensed at one time is two ounces.

      b.   A physician may issue multiple written instructions at one time authorizing the patient to receive a total of up to a 90-day supply, provided that the following conditions are met:

     (1)   Each separate set of instructions shall be issued for a legitimate medical purpose by the physician, as provided in this act;

     (2)   Each separate set of instructions shall indicate the earliest date on which a center may dispense the marijuana, except for the first dispensation if it is to be filled immediately; and

     (3)   The physician has determined that providing the patient with multiple instructions in this manner does not create an undue risk of diversion or abuse.

      c.    A registered qualifying patient or his primary caregiver shall present the patient's or caregiver's registry identification card, as applicable, and these written instructions to the alternative treatment center, which shall verify and log the documentation presented. A physician may provide a copy of a written instruction by electronic or other means, as determined by the commissioner, directly to an alternative treatment center on behalf of a registered qualifying patient. The dispensation of marijuana pursuant to any written instructions shall occur within one month of the date that the instructions were written or the instructions are void.

      d.   A patient may be registered at only one alternative treatment center at any time.

      e.    Prior to dispensing medical marijuana to a patient or to the patient's primary caregiver, the alternative treatment center shall access the patient's prescription monitoring information to determine whether the patient was dispensed medical marijuana by any alternative treatment center within the past 30 days, including alternative treatment centers located outside the State.

      f.    No later than 24 hours after dispensing medical marijuana to a qualifying patient or the patient's designated caregiver, the alternative treatment center shall report to the prescription monitoring database the following information:

     (1)   the quantity, strain, and form of medical marijuana that was dispensed;

     (2)   the name and registry card number of the qualifying patient for whom the medical marijuana was dispensed, and, if the medical marijuana was dispensed to the patient's designated caregiver, the caregiver's name and registry card number;

     (3)   the name of the physician who issued the written instructions;

     (4)   the name of the alternative treatment center that dispensed the medical marijuana; and

     (5)   such other information as the Director of the Division of Consumer Affairs in the Department of Law and Public Safety determines necessary.

(cf: P.L.2009, c.307, s.10)

 

     2.    Section 25 of P.L.2007, c.244 (C.45:1-45) is amended to read as follows:

     25.  Prescription Monitoring Program; requirements.

     a.     There is established the Prescription Monitoring Program in the Division of Consumer Affairs in the Department of Law and Public Safety. The program shall consist of an electronic system for monitoring controlled dangerous substances that are dispensed in or into the State by a pharmacist in an outpatient setting as well as medical marijuana that is dispensed to registered qualifying patients and their primary caregivers by an alternative treatment center pursuant to section 10 of P.L.2009, c.307 (C.24:6I-10).

      b.   Each pharmacy permit holder shall submit, or cause to be submitted, to the division, by electronic means in a format and at such intervals as are specified by the director, information about each prescription for a controlled dangerous substance dispensed by the pharmacy that includes:

     (1)   The surname, first name, and date of birth of the patient for whom the medication is intended;

     (2)   The street address and telephone number of the patient;

     (3)   The date that the medication is dispensed;

     (4)   The number or designation identifying the prescription and the National Drug Code of the drug dispensed;

     (5)   The pharmacy permit number of the dispensing pharmacy;

     (6)   The prescribing practitioner's name and Drug Enforcement Administration registration number;

     (7)   The name, strength, and quantity of the drug dispensed, the number of refills ordered, and whether the drug was dispensed as a refill or a new prescription;

     (8)   The date that the prescription was issued by the practitioner;

     (9)   The source of payment for the drug dispensed;

     (10)    Identifying information for any individual, other than the patient for whom the prescription was written, who picks up a prescription, if the pharmacist has a reasonable belief that the person picking up the prescription may be seeking a controlled dangerous substance, in whole or in part, for any reason other than delivering the substance to the patient for the treatment of an existing medical condition; and

     (11)    Such other information, not inconsistent with federal law, regulation, or funding eligibility requirements, as the director determines necessary.

     The pharmacy permit holder shall submit the information to the division with respect to the prescriptions dispensed during the reporting period not less frequently than every seven days. 

      c.    The division may grant a waiver of electronic submission to any pharmacy permit holder for good cause, including financial hardship, as determined by the director.  The waiver shall state the format in which the pharmacy permit holder shall submit the required information.

      d.   The requirements of this act shall not apply to:  the direct administration of a controlled dangerous substance to the body of an ultimate user; or the administration or dispensing of a controlled dangerous substance that is otherwise exempted as determined by the Secretary of Health and Human Services pursuant to the "National All Schedules Prescription Electronic Reporting Act of 2005," Pub.L.109-60.

      e.    The provisions of paragraph (10) of subsection b. of this section shall not take effect until the director determines that the Prescription Monitoring Program has the technical capacity to accept the information required by that paragraph.

      f.    Each alternative treatment center shall submit to the division, by electronic means in a format and at such intervals as are specified by the director, the information required pursuant to subsection f. of section 10 of P.L.2009, c.307 (C.24:6I-10) for any medical marijuana dispensed by the alternative treatment center.

(cf: P.L.2015, c.74, s.3)

 

     3.    Section 26 of P.L.2007, c.244 (C.45:1-46) is amended to read as follows:

     26.  Access to prescription information. 

     a.     The division shall maintain procedures to ensure privacy and confidentiality of patients and that patient information collected, recorded, transmitted, and maintained is not disclosed, except as permitted in this section, including, but not limited to, the use of a password-protected system for maintaining this information and permitting access thereto as authorized under sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50), and a requirement that a person as listed in subsection h. or i. of this section provide affirmation of the person's intent to comply with the provisions of sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50) as a condition of accessing the information.

     b.    The prescription monitoring information submitted to the division shall be confidential and not be subject to public disclosure under P.L.1963, c.73 (C.47:1A-1 et seq.), or P.L.2001, c.404 (C.47:1A-5 et al.).

     c.     The division shall review the prescription monitoring information provided by a pharmacy permit holder or alternative treatment center pursuant to sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50). The review shall include, but not be limited to:

     (1)   a review to identify whether any person is obtaining [a] written instructions for medical marijuana or any prescription in a manner that may be indicative of misuse, abuse, or diversion of a controlled dangerous substance.  The director shall establish guidelines regarding the terms "misuse," "abuse," and "diversion" for the purposes of this review.  When an evaluation of the information indicates that a person may be obtaining a prescription for the same or a similar controlled dangerous substance from multiple practitioners or pharmacists during the same time period, or may be obtaining written instructions for medical marijuana from multiple physicians or is being dispensed medical marijuana from more than one alternative treatment center in a 30-day period, the division may provide prescription monitoring information about the person to practitioners, alternative treatment centers, and pharmacists; and

     (2)   a review to identify whether a violation of law or regulation or a breach of the applicable standards of practice by any person may have occurred, including, but not limited to, diversion of a controlled dangerous substance.  If the division determines that such a violation or breach may have occurred, the division shall notify the appropriate law enforcement agency or professional licensing board, and provide the prescription monitoring information required for an investigation.

      d.   (Deleted by amendment, P.L.2015, c.74)

      e.    (Deleted by amendment, P.L.2015, c.74)

      f.    (Deleted by amendment, P.L.2015, c.74)

      g.   (Deleted by amendment, P.L.2015, c.74)

      h.   (1)   A practitioner shall register to access prescription monitoring information upon initial application for, or renewal of, the practitioner's CDS registration.

     (2)   (a)   The division shall provide to a pharmacist who is employed by a current pharmacy permit holder online access to prescription monitoring information for the purpose of providing health care to a current patient or verifying information with respect to a patient or a prescriber.

     (b)   The division shall provide online access to access to prescription monitoring information to designated staff members at each alternative treatment center for the purpose of meeting the requirements of subsection e. of section 10 of P.L.2009, c.307 (C.24:6I-10) or verifying information with respect to a physician issuing written instructions for medical marijuana.

     (3)   The division shall provide to a practitioner who has a current CDS registration online access to prescription monitoring information for the purpose of providing health care to a current patient or verifying information with respect to a patient or a prescriber. The division shall also grant online access to prescription monitoring information to as many licensed health care professionals as are authorized by a practitioner to access that information and for whom the practitioner is responsible for the use or misuse of that information, subject to a limit on the number of such health care professionals as deemed appropriate by the division for that particular type and size of professional practice, in order to minimize the burden to practitioners to the extent practicable while protecting the confidentiality of the prescription monitoring information obtained. The director shall establish, by regulation, the terms and conditions under which a practitioner may delegate that authorization, including procedures for authorization and termination of authorization, provisions for maintaining confidentiality, and such other matters as the division may deem appropriate.

     (4)   The division shall provide online access to prescription monitoring information to as many medical or dental residents as are authorized by a faculty member of a medical or dental teaching facility to access that information and for whom the practitioner is responsible for the use or misuse of that information.  The director shall establish, by regulation, the terms and conditions under which a faculty member of a medical or dental teaching facility may delegate that authorization, including procedures for authorization and termination of authorization, provisions for maintaining confidentiality, provisions regarding the duration of a medical or dental resident's authorization to access prescription monitoring information, and such other matters as the division may deem appropriate.

     (5)   (a)   The division shall provide online access to prescription monitoring information to:

     (i)    as many certified medical assistants as are authorized by a practitioner to access that information and for whom the practitioner is responsible for the use or misuse of that information;

     (ii)   as many medical scribes working in a hospital's emergency department as are authorized by a practitioner to access that information and for whom the practitioner is responsible for the use or misuse of that information; and

     (iii)   as many licensed athletic trainers working in a clinical setting as are authorized by a practitioner to access that information and for whom the practitioner is responsible for the use or misuse of that information. 

     (b)   The director shall establish, by regulation, the terms and conditions under which a practitioner may delegate authorization pursuant to subparagraph (a) of this paragraph, including procedures for authorization and termination of authorization, provisions for maintaining confidentiality, provisions regarding the duration of a certified medical assistant's, medical scribe's, or licensed athletic trainer's authorization to access prescription monitoring information, and provisions addressing such other matters as the division may deem appropriate.

     (6)   The division shall provide online access to prescription monitoring information to as many registered dental assistants as are authorized by a licensed dentist to access that information and for whom the licensed dentist is responsible for the use or misuse of that information.  The director shall establish, by regulation, the terms and conditions under which a licensed dentist may delegate that authorization, including procedures for authorization and termination of authorization, provisions for maintaining confidentiality, provisions regarding the duration of a registered dental assistant's authorization to access prescription monitoring information, and such other matters as the division may deem appropriate.

     (7)   A person listed in this subsection, as a condition of accessing prescription monitoring information pursuant thereto, shall certify that the request is for the purpose of providing health care to a current patient or verifying information with respect to a patient or practitioner.  Such certification shall be furnished through means of an online statement or alternate means authorized by the director, in a form and manner prescribed by rule or regulation adopted by the director.  If the information is being accessed by an authorized person using an electronic system authorized pursuant to subsection q. of this section, the certification may be furnished through the electronic system.

      i.    The division may provide online access to prescription monitoring information, or may provide access to prescription monitoring information through any other means deemed appropriate by the director, to the following persons:

     (1)   authorized personnel of the division or a vendor or contractor responsible for maintaining the Prescription Monitoring Program;

     (2)   authorized personnel of the division responsible for administration of the provisions of P.L.1970, c.226 (C.24:21-1 et seq.);

     (3)   the State Medical Examiner, a county medical examiner, a deputy or assistant county medical examiner, or a qualified designated assistant thereof, who certifies that the request is for the purpose of investigating a death pursuant to P.L.1967, c.234 (C.52:17B-78 et seq.);

     (4)   a controlled dangerous substance monitoring program in another state with which the division has established an interoperability agreement, or which participates with the division in a system that facilitates the secure sharing of information between states;

     (5)   a designated representative of the Department of Health, State Board of Medical Examiners, New Jersey State Board of Dentistry, State Board of Nursing, New Jersey State Board of Optometrists, State Board of Pharmacy, State Board of Veterinary Medical Examiners, or any other board in this State or another state that regulates the practice of persons who are authorized to prescribe, issue written instructions for, or dispense controlled dangerous substances, as applicable, who certifies that the representative is engaged in a bona fide specific investigation of a designated practitioner, alternative treatment center, or pharmacist whose professional practice was or is regulated by that board;

     (6)   a State, federal, or municipal law enforcement officer who is acting pursuant to a court order and certifies that the officer is engaged in a bona fide specific investigation of a designated practitioner, pharmacist, alternative treatment center, or patient. A law enforcement agency that obtains prescription monitoring information shall comply with security protocols established by the director by regulation;

     (7)   a designated representative of a state Medicaid or other program who certifies that the representative is engaged in a bona fide investigation of a designated practitioner, pharmacist, or patient;

     (8)   a properly convened grand jury pursuant to a subpoena properly issued for the records; and

     (9)   a licensed mental health practitioner providing treatment for substance abuse to patients at a residential or outpatient substance abuse treatment center licensed by the Division of Mental Health and Addiction Services in the Department of Human Services, who certifies that the request is for the purpose of providing health care to a current patient or verifying information with respect to a patient or practitioner, and who furnishes the division with the written consent of the patient for the mental health practitioner to obtain prescription monitoring information about the patient.  The director shall establish, by regulation, the terms and conditions under which a mental health practitioner may request and receive prescription monitoring information.  Nothing in sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50) shall be construed to require or obligate a mental health practitioner to access or check the prescription monitoring information in the course of treatment beyond that which may be required as part of the mental health practitioner's professional practice.

     j.     A person listed in subsection i. of this section, as a condition of obtaining prescription monitoring information pursuant thereto, shall certify the reasons for seeking to obtain that information.  Such certification shall be furnished through means of an online statement or alternate means authorized by the director, in a form and manner prescribed by rule or regulation adopted by the director. 

     k.    The division shall offer an online tutorial for those persons listed in subsections h. and i. of this section, which shall, at a minimum, include: how to access prescription monitoring information; the rights of persons who are the subject of this information; the responsibilities of persons who access this information; a summary of the other provisions of sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50) and the regulations adopted pursuant thereto, regarding the permitted uses of that information and penalties for violations thereof; and a summary of the requirements of the federal health privacy rule set forth at 45 CFR Parts 160 and 164 and a hypertext link to the federal Department of Health and Human Services website for further information about the specific provisions of the privacy rule.

     l.     The division may request and receive prescription monitoring information from prescription monitoring programs in other states and may use that information for the purposes of sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50). When sharing data with programs in another state, the division shall not be required to obtain a memorandum of understanding unless required by the other state.

     m.   The director may provide nonidentifying prescription drug monitoring information to public or private entities for statistical, research, or educational purposes, in accordance with the provisions of sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50).

     n.    Nothing shall be construed to prohibit the division from obtaining unsolicited automated reports from the program or disseminating such reports to pharmacists, practitioners, mental health care practitioners, and other licensed health care professionals, as well as to alternative treatment centers.

     o.    (1)   A current patient of a practitioner may request from that practitioner that patient's own prescription monitoring information that has been submitted to the division pursuant to sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50) or subsection f. of section 10 of P.L.2009, c.307 (C.24:6I-10). A parent or legal guardian of a child who is a current patient of a practitioner may request from that practitioner the child's prescription monitoring information that has been submitted to the division pursuant to sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50) or subsection f. of section 10 of P.L.2009, c.307 (C.24:6I-10).

     (2)   Upon receipt of a request pursuant to paragraph (1) of this subsection, a practitioner or health care professional authorized by that practitioner may provide the current patient or parent or legal guardian, as the case may be, with access to or a copy of the prescription monitoring information pertaining to that patient or child.

     (3)   The division shall establish a process by which a patient, or the parent or legal guardian of a child who is a patient, may request a pharmacy permit holder that submitted prescription monitoring information concerning a prescription for controlled dangerous substances for that patient or child to the division pursuant to sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50) or subsection f. of section 10 of P.L.2009, c.307 (C.24:6I-10) to correct information that the person believes to have been inaccurately entered into that patient's or child's prescription profile.  Upon confirmation of the inaccuracy of any such entry into a patient's or child's prescription profile, the pharmacy permit holder shall be authorized to correct any such inaccuracies by submitting corrected information to the division pursuant to sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50). The process shall provide for review by the Board of Pharmacy of any disputed request for correction, which determination shall be appealable to the director.

      p.   The division shall take steps to ensure that appropriate channels of communication exist to enable any licensed health care professional, licensed pharmacist, mental health practitioner, pharmacy permit holder, alternative treatment center, or other practitioner who has online access to the Prescription Monitoring Program pursuant to this section to seek or provide information to the division related to the provisions of this section.

      q.   (1)     The division may make prescription monitoring information available on electronic systems that collect and display health information, such as an electronic system that connects hospital emergency departments for the purpose of transmitting and obtaining patient health data from multiple sources, or an electronic system that notifies practitioners of information pertaining to the treatment of overdoses; provided that the division determines that any such electronic system has appropriate security protections in place. 

     (2)   Practitioners who are required to access prescription monitoring information pursuant to section 8 of P.L.2015, c.74 (C.45:1-46.1) may discharge that responsibility by accessing one or more authorized electronic systems into which the prescription monitoring information maintained by the division has been integrated.

(cf: P.L.2017, c.341, s.3)

     4.    Section 28 of P.L.2007, c.244 (C.45:1-28) is amended to read as follows:

     28.  Immunity from liability.

     a.     The division shall be immune from civil liability arising from inaccuracy of any of the information submitted to it pursuant to sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50) or subsection f. of section 10 of P.L.2009, c.307 (C.24:6I-10).

     b.    A pharmacy permit holder, pharmacist, alternative treatment center, mental health practitioner, licensed health care professional, or practitioner shall be immune from civil liability arising from compliance with sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50) or subsection f. of section 10 of P.L.2009, c.307 (C.24:6I-10).

(cf: P.L.2015, c.74, s.5)

 

     5.    Section 29 of P.L.2007, c.244 (C.45:1-49) is amended to read as follows:

     29.  Penalties.

     a.     A pharmacy permit holder, or a person designated by a pharmacy permit holder to be responsible for submitting data required by section 25 of P.L.2007, c.244 (C.45:1-45), or a designated employee of an alternative treatment center responsible for submitted data as required by subsection f. of section 10 of P.L.2009, c.307 (C.24:6I-10), who knowingly fails to submit data as required, shall be subject to disciplinary action pursuant to section 8 of P.L.1978, c.73 (C.45:1-21) and may be subject to a civil penalty in an amount not to exceed $1,000 for failure to comply with sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50).

      b.   (1)   A pharmacy permit holder, pharmacist, employee of an alternative treatment center, mental health practitioner, licensed health care professional, or practitioner, or any other person or entity who knowingly obtains or attempts to obtain prescription monitoring information in violation of the provisions of sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50) shall be subject to a civil penalty in an amount not to exceed $10,000.

     (2)   A pharmacy permit holder, pharmacist, mental health practitioner, licensed health care professional, or practitioner who knowingly discloses or uses prescription monitoring information in violation of the provisions of sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50), shall also be subject to disciplinary action pursuant to section 8 of P.L.1978, c.73 (C.45:1-21). An employee of an alternative treatment center who knowingly discloses or uses prescription monitoring information in violation of the provisions of sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50) shall also be subject to appropriate disciplinary action by the Department of Health.

     c.     In addition to any other penalty provided by law, a person who is authorized to obtain prescription monitoring information from the Prescription Monitoring Program who knowingly discloses such information in violation of the provisions of sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50) shall be guilty of a crime of the fourth degree and shall be subject to a civil penalty in an amount not to exceed $10,000.

     d.    In addition to any other penalty provided by law, a person who is authorized to obtain prescription monitoring information from the Prescription Monitoring Program who uses this information in the course of committing, attempting to commit, or conspiring to commit any criminal offense shall be guilty of a crime of the third degree.  Notwithstanding the provisions of N.J.S.2C:1-8 or any other provision of law, a conviction under this subsection shall not merge with a conviction of any other offense, nor shall any other conviction merge with a conviction under this subsection.  The court shall impose separate sentences upon a conviction under this subsection and any other criminal offense.

     e.     In addition to any other penalty provided by law, a person who is not authorized to obtain prescription monitoring information from the Prescription Monitoring Program who knowingly obtains or attempts to obtain such information in violation of the provisions of sections 25 through 30 of P.L.2007, c.244 (C.45:1-45 through C.45:1-50), shall be guilty of a crime of the fourth degree.

     f.     A civil penalty imposed under this section shall be collected by the director pursuant to the "Penalty Enforcement Law of 1999," P.L.1999, c.274 (C.2A:58-10 et seq.).

(cf: P.L.2015, c.74, s.6)

 

     6.    Section 11 of P.L.2009, c.307 (C.45:1-45.1) is repealed.

 

     7.    This act shall take effect 60 days after the date of enactment.

 

 

STATEMENT

 

     This bill requires medical marijuana alternative treatment centers to submit certain information concerning medical marijuana dispensed to registered qualifying patients or their designated caregivers to the prescription monitoring program administered by the Division of Consumer Affairs in the Department of Law and Public Safety. The information will include the form, strain, quantity, and potency of medical marijuana dispensed, the patient's name and registry identification number, the primary caregiver's name and registry identification number if the medical marijuana is dispensed to the caregiver, and the name of the physician and the alternative treatment center. Additionally, the bill requires alternative treatment centers to check a patient's prescription monitoring information prior to dispensing medical marijuana to the patient or the patient's primary caregiver to determine whether the patient was dispensed medical marijuana from any alternative treatment center within the past 30 days.

     The bill updates various provisions of the prescription monitoring law to reflect the provisions of the bill and repeals a statute that required the division to create a parallel reporting system for medical marijuana that was cross-referenced with the prescription monitoring database.

feedback